Skip to main content
logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
102.87
+0.49 (0.48%)
At close: Apr 2, 2026, 4:00 PM EDT
103.56
+0.69 (0.67%)
After-hours: Apr 2, 2026, 7:53 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20
United States Revenue
4.38B
United States Revenue Growth
0.97%
Total International Revenue
7.08B
Total International Revenue Growth
6.68%
Revenue (Total)
11.46B
Revenue (Total) Growth
4.42%

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20
Established Pharmaceutical Products Revenue
1.38B
Established Pharmaceutical Products Revenue Growth
8.99%
Nutritionals Revenue
1.94B
Nutritionals Revenue Growth
-8.88%
Diagnostics Revenue
2.46B
Diagnostics Revenue Growth
-2.50%
Medical Devices Revenue
5.68B
Medical Devices Revenue Growth
12.33%
Other Segment Revenue
5.00M
Revenue (Total)
11.46B
Revenue (Total) Growth
4.42%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20
Established Pharmaceutical Products Operating Earnings
255.00M
Established Pharmaceutical Products Operating Earnings Growth
-5.90%
Nutritionals Operating Earnings
386.00M
Nutritionals Operating Earnings Growth
-12.87%
Diagnostics Operating Earnings
609.00M
Diagnostics Operating Earnings Growth
-0.33%
Medical Devices Operating Earnings
1.98B
Medical Devices Operating Earnings Growth
11.56%
Operating Income (Other)
-977.00M
Operating Income (Total)
2.25B
Operating Income (Total) Growth
17.79%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20
Organic Sales Growth
3.00%
Updated Jan 22, 2026. Data Source: Fiscal.ai.